Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy (Q36064914)

11 August 2017

1 reference

title

Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy (English)

1 reference

11 August 2017

0 references

Anthony D Yang

1

1 reference

11 August 2017

Todd W Bauer

2

1 reference

11 August 2017

E Ramsay Camp

3

1 reference

11 August 2017

Ray Somcio

4

1 reference

11 August 2017

Wenbiao Liu

5

1 reference

11 August 2017

Fan Fan

6

1 reference

11 August 2017

Lee M Ellis

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

11 August 2017

1 reference

11 August 2017

103

1 reference

11 August 2017

8

1 reference

11 August 2017

1561-1570

1 reference

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

11 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

Interstitial fluid pressure in intracranial tumours in patients and in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

Determinants of drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

High interstitial fluid pressure - an obstacle in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Transport of molecules across tumor vasculature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

VEGF: an update on biological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Regulators of vascular endothelial growth factor expression in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Biology of angiogenesis in tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Role of angiogenesis in the development and growth of liver metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Regulation of vascular permeability by vascular endothelial growth factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Molecular and biological properties of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Lymphangiogenesis in tumors: what do we know?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

PDGF receptors as cancer drug targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Increasing tumor uptake of anticancer drugs with imatinib.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

A novel physiological function for platelet-derived growth factor-BB in rat dermis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Mechanism of action and in vivo role of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Carboplatin selectively induces the VEGF stress response in endothelial cells: Potentiation of antitumor activity by combination treatment with antibody to VEGF.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

The anti-angiogenic basis of metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Combined effects of angiostatin and ionizing radiation in antitumour therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Pharmacology of imatinib (STI571).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Imatinib mesylate--a new oral targeted therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Lowering of tumoral interstitial fluid pressure by prostaglandin E(1) is paralleled by an increased uptake of (51)Cr-EDTA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Interference with TGF-beta1 and -beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20942

7 January 2021

Identifiers

DOI

10.1002/CNCR.20942

1 reference

11 August 2017

1 reference